Sarah Hamidi, M.D., FRCPC
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Assistant Professor, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2017 | University of Montreal, Montreal, QC, CA, Medicinae Doctorem (M.D.) |
| 2013 | University of Montreal, Montreal, QC, CA, Pre-medical Year |
Postgraduate Training
| 2022-2024 | Advanced clinical and research fellowship, Oncologic Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2021-2022 | Chief Resident, Adult Endocrinology and Metabolism, The University of Montreal Hospital Center (CHUM), Montreal, QC |
| 2020-2022 | Clinical fellowship, Adult Endocrinology and Metabolism, University of Montreal, Montreal, QC |
| 2017-2020 | Clinical residency, Internal Medicine, University of Montreal, Montreal, QC |
Licenses & Certifications
| 2025 | Texas Medical License |
| 2022 | Board Certification in Adult Endocrinology and Metabolism by the Royal College of Physicians and Surgeons of Canada |
| 2020 | Board Certification in Internal Medicine by the Royal College of Physicians and Surgeons of Canada |
Experience & Service
Other Professional Positions
Clinical Research Scientist, Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - 2025
Intramural Institutional Committee Activities
Co-chair, ALTER ATC: Adaptive Learning to improve Thyroid Cancer Responses in Anaplastic Thyroid Cancer, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, ACTION QI: Advanced Cancers of the Thyroid early Interrogation for Oncologic and Neoadjuvant Targets, The University of Texas MD Anderson Cancer Center, 2023 - 2025
Co-leader, Safety Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy, The University of Texas MD Anderson Cancer Center, 2022 - 2025
Extramural Institutional Committee Activities
Co-chair, Continuing Professional Development Committee of the Division of Endocrinology and Metabolism, The University of Montreal Hospital Center (CHUM), 2021 - 2022
Member, Trainee representative, Continuing Professional Development Committee of Quebec's Association of Endocrinologists, Quebec's Association of Endocrinologists, 2021 - 2022
Member, Adult Endocrinology and Metabolism Fellowship Program Admissions Committee, University of Montreal, 2021
Member, Well-being Committee of the Division of Endocrinology and Metabolism, The University of Montreal Hospital Center, 2020 - 2022
Honors & Awards
| 2025 | Travel Grant for the 2025 International Thyroid Congress, American Thyroid Association |
| 2025 | Cyrus Scholar Award for Outstanding Clinical Research, The University of Texas MD Anderson Cancer Center |
| 2024 | 2024 Outstanding Trainee Poster Award, American Thyroid Association |
| 2024 | Ridgeway Trainee Travel Grant, American Thyroid Association |
| 2023 | 2023 Women Advancing Thyroid Research Award, American Thyroid Association |
| 2023 | Ridgeway Trainee Travel Grant, American Thyroid Association |
| 2023 | First place at the 2023 Division of Internal Medicine Research Retreat, Clinical Research poster session, The University of Texas MD Anderson Cancer Center |
| 2022 | Dean's Honor List - Postgraduate Medical Education, University of Montreal |
| 2022 | The Department of Medicine's Trainee Excellence Award, The University of Montreal Hospital Center (CHUM) |
| 2018 | Internal Medicine Resident Excellence Award, Maisonneuve-Rosemont Hospital, Montreal, QC |
| 2017 | Dean's Honor List - M.D, University of Montreal |
| 2012 | Highest Honors and Jury's Praise at the French Baccalaureate, Stanislas College, Montreal, QC |
Professional Memberships
Grant & Contract Support
| Date: | 2026 - Present |
| Title: | STOP-ATC – Stopping Treatment for Optimized Patient outcomes in Anaplastic Thyroid Cancer |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2025 |
| Title: | Identifying Biomarkers of Response to Radiation-Enhanced Checkpoint Blockade in non-BRAF mutated Anaplastic Thyroid Cancer |
| Funding Source: | U-Pilot Award by the U Foundation |
| Role: | Co-PI |
| Date: | 2024 - Present |
| Title: | Applying the Neoadjuvant Strategy to Non-BRAF Mutated Anaplastic Thyroid Carcinoma |
| Funding Source: | MD Anderson, Dept. of Head & Neck Surgery, ATC Multidisciplinary Petrick Research Program |
| Role: | Co-PI |
| Date: | 2024 |
| Title: | Association of the Thyroid Differentiation Score with Tumor Metabolism and Immune Phenotype |
| Funding Source: | Endocrine Fellows Foundation |
| Role: | Co-PI |
Patient Reviews
CV information above last modified July 09, 2026